A case report suspected a medication-associated movement disorder and described improvement under two drugs. It did not establish clonazepam’s independent effect.
A young man developed involuntary abdominal-wall movements after a short course of treatment including domperidone. Imaging and laboratory assessments did not identify a clear structural explanation.
The movements reportedly subsided after promethazine and clonazepam were administered. The authors proposed a drug-associated cause and discussed symptomatic management.
The preceding exposure raises a hypothesis about the trigger, while the later combined treatment raises a different question about relief. Neither chronology alone establishes exclusive causation. Natural variation and both medications can contribute to improvement.
One unusual case cannot determine response rates, an optimal regimen, or diagnostic accuracy. The report should not be summarized as proof that clonazepam cures every abdominal dyskinesia. A forensic account needs the actual movement description, exposure timing, competing causes, concurrent treatment, and duration of follow-up.
Original analysis of the supplied journal article, identified as PMC5593747.